FDA Approved: ZOLMITRIPTAN — Original Application (Padagis Israel Pharmaceuticals Ltd)

View source ↗

Summary

FDA approved the original application for zolmitriptan from Padagis Israel Pharmaceuticals Ltd, marking a new generic entry for acute treatment of migraine.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Migraine

Drugs mentioned

• Zolmitriptan (zolmitriptan)

Snippet

ORIG AP for ZOLMITRIPTAN (ZOLMITRIPTAN)